DIP
BMY icon

Davis Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Davis Investment Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$856K Buy
14,110
+1,306
+10% +$76.1K 0.3% 59
2025
Q4 		$684K Sell
12,804
-137
-1% -$6.59K 0.24% 72
2025
Q3 		$614K Sell
12,941
-1,261
-9% -$58.9K 0.21% 80
2025
Q2 		$675K Sell
14,202
-3,022
-18% -$148K 0.24% 73
2025
Q1 		$884K Buy
17,224
+9,912
+136% +$578K 0.39% 45
2024
Q4 		$408K Buy
+7,312
New +$409K 0.17% 87

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Davis Investment Partners's BMY Position: Q1 2026 in Review

Davis Investment Partners increased its Bristol-Myers Squibb (BMY) stake by 10% in Q1 2026, buying an estimated $76.1K and bringing the position to 14,110 shares worth $856K. The position accounts for 0.3% of the portfolio, ranked #59.

Davis Investment Partners first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $884K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Davis Investment Partners held 14,110 shares of Bristol-Myers Squibb worth $856K as of Q1 2026.
  • Davis Investment Partners bought 1,306 Bristol-Myers Squibb shares in Q1 2026, an estimated $76.1K.
  • Bristol-Myers Squibb made up 0.3% of Davis Investment Partners's portfolio in Q1 2026, its #59 holding.
  • Davis Investment Partners first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • Davis Investment Partners's Bristol-Myers Squibb position peaked at $884K in Q1 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Davis Investment Partners's 13F filing for Q1 2026, filed 20 Apr 2026.